Safety Syringe Global Market Report 2026

A safety syringe serves as a medical injection device equipped with integrated safety features to mitigate accidental needle stick injuries or reuse. These syringes are specifically engineered to avert needle stick injuries, which may occur when healthcare workers or individuals inadvertently puncture their skin with a used needle.

Safety syringes primarily comprise retractable safety syringes and non-retractable safety syringes. Retractable safety syringes feature a built-in mechanism enabling the needle to retract or withdraw into the syringe barrel post-injection. They find application in therapies such as insulin, glucagon-like peptide-i (GLP-1), tuberculosis, and growth hormones, catering to subcutaneous and intramuscular administration. These syringes are utilized across various healthcare settings including hospitals, ambulatory surgical centers, long-term care facilities, specialty clinics, among others.

Tariffs are impacting the safety syringe market by increasing import and material costs for stainless steel needles, medical-grade plastics, springs, and precision molding components used in retractable and non-retractable safety syringe systems, resulting in higher manufacturing and procurement expenses across hospitals, ambulatory surgical centers, and long-term care facilities. The effects are particularly evident in regions that depend on cross-border sourcing of syringe barrels, plungers, and shielding mechanisms in North America, Europe, and Asia-Pacific. These higher landed costs have created pricing pressure in public health and vaccination programs; however, tariffs are also encouraging local molding, assembly partnerships, and regional supply-chain development, generating selective positive opportunities for domestic syringe manufacturers.

The safety syringe market research report is one of a series of new reports from The Business Research Company that provides safety syringe market statistics, including safety syringe industry global market size, regional shares, competitors with a safety syringe market share, detailed safety syringe market segments, market trends and opportunities, and any further data you may need to thrive in the safety syringe industry. This safety syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The safety syringe market size has grown strongly in recent years. It will grow from $9.68 billion in 2025 to $10.52 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising incidence of needle stick injuries among healthcare workers, increasing regulatory emphasis on safe injection and single-use devices, early availability of fixed needle and shielded needle safety syringes, expansion of hospital immunization and therapeutic injection programs, growing awareness of infection prevention and occupational safety.

The safety syringe market size is expected to see strong growth in the next few years. It will grow to $14.77 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to rising demand for automatic and manual retractable safety syringes, increasing utilization in insulin clp-i tuberculosis and growth hormone therapies, growing adoption across ambulatory surgical centers and specialty clinics, expanding procurement in long-term care and chronic disease management settings, rising focus on preventing device reuse and cross-contamination. Major trends in the forecast period include rising adoption of safety syringes to minimize needle stick injury risks in healthcare settings, increasing utilization of retractable and non-retractable safety syringes across therapeutic injections, growing preference for automatic and manual retractable safety syringe designs, expansion of safety syringe use in subcutaneous and intramuscular drug administration, increasing deployment of safety syringes across hospitals ascs and long-term care facilities.

The increasing incidence of blood-borne diseases is expected to drive the growth of the safety syringe market in the coming years. Blood-borne diseases are infectious conditions caused by microorganisms such as bacteria, viruses, or parasites that are transmitted through exposure to infected blood. Safety syringes serve as a preventive solution to safeguard both healthcare professionals and patients by minimizing the risk of accidental needle-stick injuries and reducing unintended exposure to contaminated blood, while also supporting safer clinical practices. For example, in November 2024, according to the UK Health Security Agency, a UK-based government agency, during the first 24 months, 34 emergency departments conducted 1,981,590 HIV tests, 1,502,799 hepatitis C tests, and 1,185,678 hepatitis B tests, resulting in a significant increase in the annual volume of blood-borne virus testing in England. Consequently, the growing burden of blood-borne diseases is contributing to the expansion of the safety syringe market.

Companies operating in the safety syringe market are increasingly focusing on the development of innovative products, such as glass vaccine syringes, to strengthen their competitive positioning. A glass vaccine syringe is a medical device manufactured from glass and used for vaccine administration, offering a sterile option for delivering injectable medications. For instance, in March 2024, Hindustan Syringes and Medical Devices, an India-based medical device manufacturer, introduced the Dispojekt single-use safety syringe featuring an integrated safety shield known as SIP Shield. The Dispojekt syringe is designed to reduce needle-stick injuries, lower infection-control and disposal costs, and enhance workplace safety for healthcare professionals. Hindustan Syringes and Medical Devices invested approximately ₹70 crore in the initial phase of production and plans to scale capacity to 300 million units annually. The Dispojekt syringe is positioned as an affordable, domestically manufactured safety syringe targeted at developing markets and is reported to be nearly half the cost of comparable safety syringes used in the United States and Europe, supporting broader adoption and improved infection-prevention outcomes.

In December 2024, Novo Holdings A/S, a Denmark-based life sciences investment company, acquired Catalent, Inc. for approximately $16.5 billion. Through this acquisition, Novo Holdings aims to strengthen its capabilities in sterile fill-and-finish operations, prefilled syringe manufacturing, and injectable supply chains, enabling its portfolio companies to address rising global demand for injectable biologics and drug-device combination products. Catalent, Inc. is a US-based contract development and manufacturing organization specializing in drug-delivery technologies, sterile manufacturing, prefilled syringes, and biologics supply for pharmaceutical and biotechnology companies.

Major companies operating in the safety syringe market are Cardinal Health Inc., Retractable Technologies Inc., Novo Nordisk A/s, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Terumo Corporation, B. Braun Melsungen AG, West Pharmaceutical Services Inc., Fresenius Kabi AG, Nemera, Smiths Medical International Ltd., Nipro Medical Corporation, Henke-Sass Wolf GmbH, Revolutions Medical Inc., Sol-Millennium Inc., UltiMed Inc., Unilife Corporation, AdvaCare Pharma, Axol Bio Corporation, Vita Needle Company, Numedico Technologies Pty Ltd., Duopross Meditech Corporation, DMC Medical Ltd., Guangdong Haiou Medical Apparatus Co. Ltd., Kendall Healthcare Group Ltd.

North America was the largest region in the safety syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the safety syringe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the safety syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The safety syringe market consists of sales of retractable syringes, needleless syringes, safety syringe accessories, needle removers and blood collection devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Safety Syringe Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses safety syringe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for safety syringe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The safety syringe market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Retractable Safety Syringes; Non Retractable Safety Syringes
• 2) By Therapy: Insulin; Glucagon-like peptide-I (CLP-I); Tuberculosis; Growth Hormones
• 3) By Application: Subcutaneous; Intramuscular
• 4) By End-user: Hospitals; Ambulatory Surgical Centers; Long-term Care Facilities; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Retractable Safety Syringes: Automatic Retractable Safety Syringes; Manual Retractable Safety Syringes
• 2) By Non-Retractable Safety Syringes: Fixed Needle Safety Syringes; Shielded Needle Safety Syringes
• Companies Mentioned: Cardinal Health Inc.; Retractable Technologies Inc.; Novo Nordisk A/s; Becton Dickinson and Company; Baxter International Inc.; Medline Industries LP; Terumo Corporation; B. Braun Melsungen AG; West Pharmaceutical Services Inc.; Fresenius Kabi AG; Nemera; Smiths Medical International Ltd.; Nipro Medical Corporation; Henke-Sass Wolf GmbH; Revolutions Medical Inc.; Sol-Millennium Inc.; UltiMed Inc.; Unilife Corporation; AdvaCare Pharma; Axol Bio Corporation; Vita Needle Company; Numedico Technologies Pty Ltd.; Duopross Meditech Corporation; DMC Medical Ltd.; Guangdong Haiou Medical Apparatus Co. Ltd.; Kendall Healthcare Group Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.